2022 International Congress Archives - Page 150 of 153

Safety and efficacy of treadmill training combined with music on motor outcomes in patients with Parkinson’s disease: A systematic review.

M. Shahien, A. Azzam, A. Ramadan, D. Hasan, A. Elaraby (Cairo, Egypt)
Safety and Efficacy of unilaterally Focused Ultrasound Subthalamotomy in Early Parkinson´s Disease: The EARLY FOCUS I Study

E. Natera-Villlaba, R. Martínez-Fernández, R. Rodríguez-Rojas, M. Del Alamo, J. Pineda-Pardo, I. Obeso, F. Hernández-Fernández, C. Gasca-Salas, M. Matarazzo, J. Obeso (Móstoles, Madrid, Spain)
Safety and Efficacy of Verdiperstat, a Novel Myeloperoxidase Inhibitor, in MSA

I. Qureshi, V. Wirtz, L. Brady, J. Ellison, A. Ellenbogen, R. Freeman, G. Höglinger, H. Kaufmann, A. Lang, P. Low, W. Meissner, P. Millar Vernetti, H. Morris, J. Palma, S. Perlman, W. Poewe, J. Schmahmann, K. Seppi, W. Singer, S. Vernino, G. Wenning (New Haven, USA)
Safety and Tolerability of Apomorphine Sublingual Film and Subcutaneous Apomorphine for the Treatment of OFF Episodes in Parkinson’s Disease

O. Rascol, W. Poewe, F. Stocchi, R. Chaudhuri, J. Kassubek, L. Lopez Manzanares, V. Leta, I. Zhang, A. Bowling, S. Wu, E. Pappert (Toulouse, France)
Safety and tolerability of Nilotinib in patients with Huntington’s disease

K. Anderson (Washington, USA)
Safety of incobotulinumtoxinA in pediatrics: A pooled analysis

F. Heinen, M. Banach, E. Dabrowski, D. Gaebler-Spira, H. Chambers, S. Schroeder, T. Geister, M. Althaus, A. Hanschmann, S. Berweck (Munich, Germany)
Safety of opicapone after 5 years of post-marketing experience worldwide

L. Guedes, J. Graça, M. Sampaio, M. Vieira, F. Rocha, H. Gama (Coronado, Portugal)
Safety, Target Engagement and Effects of Bosutinib in Dementia with Lewy Bodies

F. Pagan, Y. Torres-Yaghi, M. Hebron, R. Turner, B. Wilmarth, S. Matar, D. Ferrante, J. Ahn, C. Moussa (Washington, USA)
Safinamide adherence: the experience of the movement disorder unit of Trieste.

M. Catalan, M. Liccari, V. Tommasini, L. Antonutti, P. Manganotti (Trieste, Italy)
Safinamide as an adjunct to Levodopa Therapy in Asian and Caucasian Patients with Parkinson’s Disease and Motor Fluctuations: A post-hoc Analysis of the SETTLE study

R. Bhidayasiri, T. Ishida, RE. Husni, T. Kamei, I. Suzuki, SL. Wu, JW. Cho (Bangkok, Thailand)
SAFINAMIDE: REAL LIFE STUDY. EFFICACY IN SWITCH FROM RASAGILINA AND LOW-DOSE TREATMENT.

MI. Morales-Casado, N. López-Ariztegui, DD. García-Meléndez, A. Diezma-Martín (Toledo, Spain)
Sarcopenia Screening with Limb Circumference and Impacts of Sarcopenia in Parkinson’s disease

SJ. Kim, YJ. Jeong, SM. Cheon ()
SARS-CoV-2 Infection and Spinocerebellar Ataxia 12: Demographics, Outcomes and Post- COVID Spectrum

IS. Singh, VS. Swarup, AKS. Srivastava (New Delhi, India)
Satisfaction level: quality of life, motor and non-motor symptoms outcomes of Mexican PD patients after deep brain stimulation.

P. Bazán-Rodríguez, E. Reséndiz-Henríquez, E. Ichikawa-Escamilla, AJ. Hernández-Medrano, GI. Cerda-Hernández, MA. Ruiz-Mafud, L. Bazán-Rodríguez, C. Martínez-Cortés, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)
SCA5 – A new Cause of Parkinsonism?

Y. Trufanov, N. Svyrydova, A. Galusha (Kyiv, Ukraine)
Scaling the Roche Digital Health Technology Platform to Assess Disease Severity and Progression in Individuals with Parkinson’s Disease

W. Popp, K. Taylor, A. Bamdadian, L. Restelli, J. Schjodt-Eriksen, G. Pagano, H. Svoboda, A. Bonni, M. Lindemann (Basel, Switzerland)
SCFAs participate in the pathogenesis of Parkinson’s disease by regulating NLRP3 inflammasomes activation

Z. Mao, J. Xiong, Z. Min, Z. Xue (Wuhan, China)
Scoring Algorithm-Based Genomic Testing in Dystonia- A Validation study from a Single Centre Cohort from India

VV. Holla, K. Neeraja, A. Stezin, M. Netravathi, N. Kamble, R. Yadav, PK. Pal (Bengaluru, India)
Scoring Algorithm-Based Genomic Testing in Dystonia: real-life data from the outpatient clinic

E. Indelicato, M. Amprosi, A. Eigentler, W. Nachbauer, R. Granata, M. Zech, S. Boesch (Innsbruck, Austria)
Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative

Z. Meyer, C. Marras, A. Naito, N. Dahodwala, A. Ramirez-Zamora, M. Rose Rafferty, M. Neault, J. Beck, R. Deleon, T. Davis, S. Mantri, K. Mills, J. Miyasaki, E. Nelson, A. Brown, D. Weintraub, A. Allen (Miami, USA)
Screening of autistic traits in people with functional neurological disorders

B. Gonzalez-Herrero, F. Morgante, J. Pagonabarraga, B. Stanton, M. Edwards (London, United Kingdom)
Screening of REM Sleep Behavior Disorder and the relation with parkinsonism symptoms in the elderly in southern Brazil: a preliminary population-based study

G. Pereira, N. Soares, E. Moriguchi, J. Senger, M. Sartori, N. Bruscato, C. Bertocchi, L. Netson, R. Almeida, A. Schumacher-Schuh, C. Rieder (Porto Alegre, Brazil)
Second Project: The feasibility and efficacy of virtual visits compared to in-person visits for management of Parkinson’s disease. A pilot, international, longitudinal, multicenter trial (NCT04695353).

A. García-Bustillo, O. Ojo, N. Okubadejo, JH. Ahn, J. Youn, E. Eldayem, A. Shalash, A. Cardozo, Z. Aldaajani, J. Bajwa, M. Spindler, M. Shackleford, Z. Mari, E. Cubo (Burgos, Spain)
Secondary generalized myoclonus resulting from brainstem ischemic lesion

S. Saaf, A. Miqdadi, S. Lhassani, M. Hakimi, J. Aasfara, A. Hazim (Casablanca, Morocco)
Selection of clinical doses for SBT101, an AAV9-hABCD1 vector for the treatment of adrenomyeloneuropathy

D. Anderson, C. Maguire, C. Ng, Y. Gong, F. Eichler, S. Fourcase, C. Guilera, A. Pujol, A. Onieva, M. Leal-Julià, S. Verdés, A. Bosch, I. Dijkstra, S. Kemp, H. Park, T. Del Rio, T. Lutz, V. Vasireddy, S. Clark, K. Kozarsky (Bala Cynwyd, USA)
SelfCog®: a digitized cognitive battery to classify Parkinson disease (PD) patients with or without Mild Cognitive Impairment (MCI)

J. Montillot, R. Massart, K. Hernandez, M. Lunven, G. Fénelon, H. Salhi, A. Bachoud-Lévi, P. Rémy (Créteil, France)
Sensor-based gait analysis in the premotor stage of LRRK2 G2019S-associated Parkinson’s disease

A. Sánchez Rodríguez, C. Tirnauca, D. Salas-Gómez, M. Fernández-Gorgojo, I. Martínez Rodríguez, M. Sierra, I. González Aramburu, D. Stan, A. Gutierrez-González, J. M Meissner, J. Andrés Pacheco, M. Rivera Sánchez, M. Sánchez-Peláez, P. Sánchez Juan, J. Infante (Santander, Spain)
Sensorimotor retraining program based on the principles of S.P.R.Int (SensoriMotor perceptive Integrated) in association with E.M.D.R (Eye Movement Desensitization and Reprocessing): a new proposal for treatment in Functional Movement Disorders (FMD)- a case report

A. Castagna, A. D'Amico, M. Genevini, M. Ramella (Milano, Italy)
Serial Cases: Blepharospasm With Oromandibular Dystonia (Meige Syndrome) (Rare Case)

NER. Raisa, ULA. Abshor (Malang, Indonesia)
Serum Metabolomic Characterization of PLA2G6-associated Dystonia-Parkinsonism: a case-control biomarker study

C. Chen, M. Lou, Y. Sun, W. Wang, J. Wang (Shanghai, China)
SETTING UP A PEDIATRIC DEEP BRAIN STIMULATION UNIT

J. Ferrero-Turrión, A. Salazar-Villacorta, A. Bescos, G. Español, L. Ispierto, R. Alvarez, M. Tardáguila, J. Muñoz, L. Ventura-Expósito, B. Pérez-Dueñas (Barcelona, Spain)
Sex Differences for Tau Association with Cognition in Early Parkinson’s Disease

E. Bayram, A. Tsai, K. Wang, I. Litvan (La Jolla, USA)
Sex differences in vascular risk factors for Parkinson’s disease

K. Tsutsumi, E. Shah, A. Siddiqui, I. Attaripour (Orange, USA)
Sex Modulates Cognitive Association of Lewy Body Pathology

E. Bayram, K. Wang, A. Tsai, D. Coughlin, I. Litvan (La Jolla, USA)
Sex-specific factor analysis-derived profile of neuropsychiatric symptoms predicting dementia conversion in Parkinson’s disease

Y. Lee, SW. Kang, SH. Yoon, K. Baik, HK. Na, YH. Sohn, PH. Lee (Seoul, Republic of Korea)
Sexual dysfunctions in Parkinson’s disease and their influence on partnership – data from the PRISM study

T. Kinateder, D. Marinho, L. Hatzler, D. Gruber, G. Ebersbach, F. Gandor (Beelitz-Heilstaetten, Germany)
Shared molecular genetic factors influence brain morphometry and Parkinson’s disease risk

L. Garcia-Marin, P. Reyes, Z. Ceja, N. Ogonowski, B. García-Vilchis, A. Ruiz-Contreras, D. Vazquez-Guevara, S. Alcauter, E. Morelos, A. Medina-Rivera, B. Mitchell, M. Rentería (Brisbane, Australia)
Short and long-term cental action of botulinum neurotoxin treatment in laryngeal dystonia

L. O'Flynn, K. Simonyan (Boston, USA)
Short and long-term Impact of Covid-19 Pandemic on motor and non-motor symptoms in Leucine-rich repeat kinase2 (LRRK2) associated Parkinson’s disease

A. Nasri, S. Mrabet, Y. Abida, A. Souissi, A. Gharbi, A. Gargouri, I. Kacem, R. Gouider (Tunis, Tunisia)
Short report in a dystonia cohort patients with implanted DBS systems

B. Mukhammedaminov, A. Sufianov, A. Orlov (Tashkent, Uzbekistan)
Short-latency afferent inhibition for the assessment of cholinergic degeneration in Parkinson’s disease

E. D'Angremont, I. Zijdewind, S. Vander Zee, E. de Vries, T. van Laar, I. Sommer (Groningen, Netherlands)
Sigma Absolute Spectral Power is Associated with Depression in Parkinson’s Disease

A. Memon, C. Catiul, Z. Irwin, J. Pilkington, A. Joop, R. Memon, K. Wood, G. Cutter, S. Miocinovic, A. Amara (Birmingham, USA)
Silencing dopamine neurons during sleep slows disease progression in parkinsonian mice

C. Meng, G. Cui (Research Triangle Park, USA)
Single-cell characterization of patient midbrain tissue reveals tissue remodeling and glial activation in Parkinson’s disease

S. Smajic, C. Prada-Medina, Z. Landoulsi, J. Ghelfi, S. Delcambre, C. Dietrich, J. Jarazo, J. Henck, S. Balachandran, S. Pachchek, C. Morris, P. Anotny, B. Timmermann, S. Sauer, S. Pereira, J. Schwamborn, P. May, M. Spielmann (Esch-sur-Alzette, Luxembourg)
Sisters with a novel compound heterozygous mutation in GCH1 gene linked to dopa responsive dystonia

M. Demirkiran, M. Balal, A. Bisgin (Adana, Turkey)
Sleep Disorders in Normotensive Hydrocephalus

S. Regalbuto, M. Terzaghi, M. Todisco, R. Zangaglia, F. Valentino, C. Pacchetti (Pavia, Italy)
sleep disturbance and wakefulness in parkinson’s disease

A. Tohirjonova, м. Tohirjonov (Tashkent, Uzbekistan)
Sleep in adult-onset idiopathic focal cervical dystonia (AOIFCD): an evaluation using self-reported and accelerometer derived measures

G. Bailey, M. Wadon, S. Komarzynski, K. Szewczyk-Krolikowski, A. Moore, C. Matthews, EH. Davies, K. Peall (Cardiff, United Kingdom)
Sleep stability, arousals and cycle structure in alfa-synucleinopathies: a comparative study between isolated REM sleep behaviour disorder (iRBD), Parkinson’s Disease (PD) and Dementia with Lewy Bodies (DLB)

M. Magriço, P. Bugalho (Lisboa, Portugal)
Sleep-wake disturbance in Creutzfeldt-Jakob disease mimicking fatal familial insomnia

T. Thammongkolchai, A. Charoensri, S. Liamsombut, P. Termsarasab (Bangkok, Thailand)
Smoking and Substantia Nigra Neuron Density in the Presence and Absence of Lewy Pathology

G. Ross, R. Abbott, H. Petrovitch, J. Duda, J. Uyehara-Lock, K. Masaki, C. Tanner (Honolulu, USA)
Social cognition and emotional processing in functional movement disorders

A. Tomic, I. Petrovic, M. Jecmenica Lukic, N. Dragasevic Miskovic, N. Kresojevic, V. Markovic, M. Svetel, V. Kostic (Belgrade, Serbia)
Social cognition in Parkinson’s disease

G. Siripurapu, R. Rajan, D. M R, E. A, A. Gupta, V. V Y, M. Singh, R. Bhatia, M. Tripathi, A. Srivastava, M. Srivastava, B. Verma, D. Biswas (NEW DELHI, India)
Social cognition in patients with cerebellar neurodegenerative disorders

O. Tamas, M. Kostic, A. Kacar, A. Milovanovic, B. Salak Djokic, D. Stanisavljevic, E. Stefanova, N. Dragasevic Miskovic (Belgrade, Serbia)
Social media consumption in adolescents with tics

J. Frey, T. Tholanikunnel, H. Simpson, L. Kugler, M. Wajid, I. Malaty (Gainesville, USA)
Social Withdrawal in Parkinson’s Disease: A Scoping Review

S. Ahn, K. Springer, J. Gibson (Charlottesville, USA)
Socio-Clinical Factors Associated with Parkinson’s Disease Related Specific Self-Management Behaviors: The Role of Non-Motor Symptoms

M. Kafri, M. Abu Taieh, M. Duvdevani, I. Schlesinger, M. Nassar, I. Erich, R. Hadad, G. Yogev-Seligmann (Haifa, Israel)
Socio-economic factors influencing Parkinson’s disease self-management

L. Ambrosio, C. Rodríguez-Blazquez, M. Rodriguez Violante, T. Arakaki, N. Garretto, M. Serrano-Dueñas, I. Ibañez (Southampton, United Kingdom)
Specificity of neuronal activity in globus pallidus in patients with DYT1 dystonia

I. Dzhalagoniya, S. Usova, A. Gamaleya, A. Tomskiy, A. Sedov (Moscow, Russian Federation)
Spectral somatotopy of the human subthalamic nucleus in Parkinson’s disease

A. Averna, I. Debove, A. Nowacki, K. Peterman, E. Bernasconi, M. Sousa, L. Alva, L. Lachenmayer, M. Schuepbach, C. Pollo, P. Krack, K. Nguyen, G. Tinkhauser (Bern, Switzerland)
Spectrum of Movement Disorder Emergencies in a Tertiary Care Centre in India: A prospective Observational Study

A. Bhoyar, R. Yadav, P. Pal, R. Mahale, N. Kamble, V. Holla (BANGLORE, India)
Spectrum of movement disorders in paediatric anti NMDAR encephalitis

A. Datta, A. Mukherjee, A. Pandit (Kolkata, India)
Speech disorders and axial motor impairment in advanced Parkinson’s Disease: two sides of the same coin?

G. Di Rauso, C. Budriesi, F. Cavallieri, A. Gessani, S. Coniglio, V. Rispoli, F. Valzania, F. Antonelli (Modena, Italy)
Speech markers of Presymptomatic and Prodromal Huntington’s disease

A. Vogel, C. Chan, G. Stuart, P. Maruff, Y. Lie, J. Stout (Melbourne, Australia)
Spinal cord stimulation for gait problems in Parkinson´s disease: Long term report and placebo viability

R. Carra, J. Menezes, T. Capato, K. Duarte, R. Cury (Sao Paulo, Brazil)
Spinocerebellar ataxia 21 and phenotypic variability within a family

M. Hull, M. Parnes, J. Jankovic (Houston, USA)
Spinocerebellar Ataxia Type 5: an Unusual Infantile Onset with Development Delay

S. Gallo, L. Magistrelli, E. Contaldi, I C. Campini, R. Cantello, C. Comi (Novara, Italy)
Sporadic progressive ataxia and palatal tremor: a case series

A. Fuentes, I. Bledsoe, C. Dietiker, J. Maas, E. Brown (San Francisco, USA)
Statin use and incidence of Parkinson’s disease in women from the French E3N cohort study

TTH. Nguyen, A. Fournier, E. Courtois, F. Artaud, S. Escolano, P. Tubert-Bitter, MC. Boutron-Ruault, I. Degaey, E. Roze, M. Canonico, I. Ahmed, ACM. Thiébaut, A. Elbaz (Villejuif, France)
Status Update of EPSILON: a Phase III, Randomised, Placebo-Controlled Study of Opicapone in Early Parkinson’s Disease

J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, J. Moreira, J-F. Rocha, P. Soares-da-Silva (Lisbon, Portugal)
STN-DBS Targeting SNr Modulates Sleep in Parkinson’s Disease: A Proof-of-Concept Study

HL. Yu, LX. Guan, YN. Sui, F. Ba, LM. Li (Beijing, China)
Striatal Blood brain barrier opening in Parkinson´s disease

C. Gasca-Salas, J. Pineda-Pardo, B. Fernández-Rodríguez, I. Obeso, F. Hernández-Fernández, C. Trompeta, R. Martínez-Fernández, M. Matarazzo, D. Mata-Marín, P. Guida, G. Foffani, G. Toltsis, I. Rachmilevitch, J. Blesa, R. Rodríguez-Rojas, M. Del-Alamo, J. Obeso (Móstoles, Spain)
Striatal Subregion Analysis Associated with REM Sleep Behavior Disorder in Parkinson’s disease

IH. Kwak, HI. Ma, YE. Kim, YJ. Kim (Anyang, Republic of Korea)
Structural and metabolic brain correlates of arithmetic word-problem solving in Huntington´s disease

A. Horta-Barba, S. Martinez-Horta, F. Sampedro, J. Perez-Perez, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)
Structural connectivity affecting freezing of gait after globus pallidus internus deep brain stimulation in Parkinson’s disease

S. Lee, S. Jo, J. Lee, M. Kim, H. Lee, S. Chung (Seoul, Republic of Korea)
Structural MRI features of glucocerebrosidase (GBA)-associated Parkinson’s disease

R. Patel, T. Stoub, B. Cozzi, G. Pal (Chicago, USA)
Structural MRI prediction of freezing of gait in Parkinson’s disease after deep brain stimulation

T. Ollivier, R. Viard, A. Rolland, R. Lopes, L. Defebvre, G. Kuchcinski, D. Devos, C. Moreau (Lille, France)
Studies on stigma in Parkinson’s disease in the world. A literature review

S. Kibrit, AV. Karacan, G. Kayis, R. Yilmaz, MC. Akbostancı (Ankara, Turkey)
Study of age related neurodegeneration of Cerebellum Basal Ganglia direct subcortical white matter tracts using fixel-based analysis.

V. Radhakrishnan, C. Gallea, C. Kesavadas, B. Thomas, S. Krishnan, A. Kishore (Trivandrum, India)
Study of retinal and optic nerve ganglion cell layer in Parkinson’s disease and asymptomatic carriers of the LRRK2-G2019S mutation

A. Cerveró, A. Sánchez-Rodríguez, M. Rivera-Sánchez, I. Martínez-Rodríguez, M. Sierra, I. González-Aramburu, A. Gutiérrez-González, J. Andrés-Pacheco, A. Casado, J. Infante (Santander, Spain)
Studying Care Patterns and Support Preferences Among People Living with Parkinson’s Disease

C. Pearson, M. Feeney, A. Willis, N. Yarab, R. Dolhun, V. Todaro, S. Rosenfeld (Chicago, USA)
Subclinical cognitive patterns of caudate-anchored connectivity in early Parkinson’s disease

S-W. Yoo, J-S. Kim, K-S. Lee (Seoul, Republic of Korea)
Subcortical Atrophy and Fall Risk in Parkinson’s Disease

S. Aggarwal, J. Ma, M. Salgado, M. Hamed (Chicago, USA)
Subcutaneous Foslevodopa/Foscarbidopa in Patients With Advanced Parkinson’s Disease: Results From a Randomized, Double-blind, Double-dummy Phase 3 Trial

M. Soileau, M. Spindler, J. Aldred, K. Budur, N. Fisseha, V. Fung, A. Jeong, T. Kimber, K. Klos, I. Litvan, D. O’Neill, W. Robieson, D. Standaert, S. Talapala, E. Okeanis Vaou, H. Zheng, M. Facheris, R. Hauser (Georgetown, USA)
Subgroup analyses by Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) of patients treated with levodopa inhalation powder 84mg or placebo to treat OFF symptoms in patients with Parkinson’s disease (PD)

D. Grosset, P. Zhao, R. Marini, R. Cohen, B. Blank (Glasgow, United Kingdom)
Subjective Self-Report on Sexual Problems in Parkinson’s disease is Reliable

G. Bronner, S. Peleg Nesher, Y. Manor, A. Rosenberg, S. Naor, A. Ezra, N. Geriani, T. Gurevich (Tel Aviv, Israel)
Substantia nigra dopaminergic neuron density in PD, PSP and MSA: An interim clinicopathological analysis

E. Backman, L. Saari, M. Gardberg, V. Kaasinen (Turku, Finland)
Subthalamic beta bursts reflect the continuous stochastic fluctuations of ongoing oscillations in Parkinson’s disease

J. Pardo-Valencia, C. Fernández-García, F. Alonso-Frech, G. Foffani (Móstoles, Spain)
Subthalamic tremor-related oscillatory neurons play a role in the generation of Parkinson’s tremor

P. Zhuang, M. Hallett, D. Meng, Y. Zhang, P. Li, J. Li (Beijing, China)
Successful deep brain stimulation for bilateral Holmes tremor caused by progressive multifocal encephalopathy.

T. D'Aguiar Rosa, L. Dixon, M. Khalid Yousaf, V. Holiday, A. Zemmar, J. Neimat, P. Hedera (Louisville, USA)
Successful treatment of Stiff Person Syndrome with botulinum toxin

A. Gonçalves, F. Brunet, D. Ariton, O. de Fabregues (Loures, Portugal)
Surgical outcomes in Rare Movement Disorders: A report of seventeen patients from India

VV. Holla, D. Dhar, N. Kamble, R. Yadav, D. Srinivas, PK. Pal (Bengaluru, India)
Survival and progression in GBA-associated dementia with Lewy bodies

T. Shiner, A. Mirelman, Y. Piura, A. Migirov Sandrovitz, L. Raif, S. Korenblum, O. Goldstein, G. Kave, M. Gana Weisz, A. Bar Shira, T. Gurevich, A. Orr-Urtreger, N. Giladi, N. Bregman (Tel Aviv, Israel)
Sweetspot analysis of Deep Brain Stimulation in Parkinson´s disease: Beyond the subthalamic nucleus?

J. Garcia-Cornet, B. Pascual-Sedano, A. Campolongo, JA. Aibar-Duran, R. Rodriguez-Rodriguez, J. Kulisevsky, I. Aracil-Bolaños (Barcelona, Spain)
Swimming against the current: Successful implementation of functional neurosurgery programs in underserved regions of Chile

M. Contreras Pinto, J. Hortal, G. Fernandez (la serena, Chile)
Symptomatic brain calcifications in two patients with JAM2 monoallelic variants.

S. Andretta, G. Bonato, M. Mainardi, L. Salviati, A. Antonini, M. Carecchio (Padova, Italy)
Synaptic density in cortical and subcortical gray matter is associated with mild parkinsonian signs (MPS) in healthy older adults: a [11C] UCB-J PET study

M. van Cauwenberge, A. Delva, T. Vande Casteele, A. Radwan, M. Laroy, K. van Laere, S. Sunaert, J. Vanden Stock, F. Bouckaert, L. Emsell, W. Vandenberghe, M. Vandenbulcke (Leuven, Belgium)
Synaptic Zn2+ Contribution to Parkinson’s Disease Pathophysiology: Pharmacological & Genetic Studies in Preclinical Mouse Models

AM. Ouagazzal, J. Sikora (Marseille, France)
Systematic Literature Review of Key Outcomes Used to Assess Adjunctive Treatments for Parkinson’s Disease

A. Thach, M. Zichlin, M. Peddle, M. Du, A. Lerner, N. Kirson, A. Bowling, D. Mehta, R. Williams (Marlborough, USA)
Systematic mapping of Parkinson’s disease gene interactions

P. Antony, J. Forster, O. Kondratyeva, S. Köglsberger, R. Krüger (Belvaux, Luxembourg)
Systematic Review and Network Meta-Analysis of COMT and MAO-B Inhibitors in Parkinson’s Patients with Motor Fluctuations

G. Castilla-Fernández, M. Fonseca, J. Ferreira, J-F. Rocha (Coronado, Portugal)